Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium

References

• Kushnir VA, Darmon SK, Barad DH, Gleicher N. Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation. BMJ Open. 2018;8(11):e023124. doi:10.1136/bmjopen-2018-023124
   PubMed Web of Science ®Google Scholar
• Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol. 1985;92(4):385–393. doi:10.1111/j.1471-0528.1985.tb01113.x3921051
   PubMedGoogle Scholar
• Orvieto R, Patrizio P. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate. Reprod Biomed Online. 2013;26(1):4–8. doi:10.1016/j.rbmo.2012.11.00123186555
   PubMed Web of Science ®Google Scholar
• Devroey P, Aboulghar M, Garcia-Velasco J, et al. Improving the patient‘s experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod. 2009;24(4):764–774. doi:10.1093/humrep/den46819153090
   PubMed Web of Science ®Google Scholar
• Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9(6):515–522. doi:10.1093/humupd/dmg04514714588
   PubMed Web of Science ®Google Scholar
• Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab. 2004;15(2):84–90. doi:10.1016/j.tem.2004.01.00915036255
   PubMed Web of Science ®Google Scholar
• Kolibianakis EL, Bourgain C, Albano C, et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002;78(5):1025–1029. doi:10.1016/S0015-0282(02)03323-X12413988
   PubMed Web of Science ®Google Scholar
• Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online. 2007;14:640–649. doi:10.1016/S1472-6483(10)61059-017509210
   PubMed Web of Science ®Google Scholar
• Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23:560–579. doi:10.1093/humupd/dmx01728903472
   PubMed Web of Science ®Google Scholar
• Xu B, Zhou M, Wang J, et al. Increased AIF-1-mediated TNF-α expression during implantation phase in IVF cycles with GnRH antagonist protocol. Hum Reprod. 2018;33(7):1270–1280. doi:10.1093/humrep/dey11929897458
   PubMed Web of Science ®Google Scholar
• Bukulmez O, Carr BR, Doody KM, Doody KJ. Serum cetrorelix concentrations do not affect clinical pregnancy outcome in assisted reproduction. Fertil Steril. 2008;89(1):74–83. doi:10.1016/j.fertnstert.2007.02.05917662281
   PubMed Web of Science ®Google Scholar
• Eftekhar M, Dehghani Firouzabadi R, Karimi H, Rahmani E. Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol. Iran J Reprod Med. 2012;10(4):297–302.25246889
   PubMedGoogle Scholar
• Parmar T, Gadkar-Sable S, Savardekar L, et al. Protein profiling of human endometrial tissues in the midsecretory and proliferative phases of the menstrual cycle. Fertil Steril. 2009;92(3):1091–1103. doi:10.1016/j.fertnstert.2008.07.173418793766
   PubMed Web of Science ®Google Scholar
• Hernandez ER. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod. 2000;15(6):1211–1216. doi:10.1093/humrep/15.6.121110831542
   PubMed Web of Science ®Google Scholar
• Rackow BW, Kliman HJ, Taylor HS. GnRH antagonists may affect endometrial receptivity. Fertil Steril. 2008;89(5):1234–1239. doi:10.1016/j.fertnstert.2007.02.05918410932
   PubMed Web of Science ®Google Scholar
• Altmae S, Esteban FJ, Stavreus-Evers A, et al. Guidelines for the design, analysis and interpretation of ‘omics‘ data: focus on human endometrium. Hum Reprod Update. 2014;20(1):12–28. doi:10.1093/humupd/dmt04824082038
   PubMed Web of Science ®Google Scholar
• Prior JC, Naess M, Langhammer A, Forsmo S. Ovulation prevalence in women with spontaneous normal-length menstrual cycles – a population-based cohort from HUNT3, Norway. PLoS One. 2015;10(8):e0134473. doi:10.1371/journal.pone.013447326291617
   PubMed Web of Science ®Google Scholar
• Wisniewski JR, Vildhede A, Noren A, Artursson P. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. J Proteomics. 2016;136:234–247. doi:10.1016/j.jprot.2016.01.01626825538
   PubMed Web of Science ®Google Scholar
• Nielsen PA, Olsen JV, Podtelejnikov AV, Andersen JR, Mann M, Wisniewski JR. Proteomic mapping of brain plasma membrane proteins. Mol Cell Proteomics. 2005;4(4):402–408. doi:10.1074/mcp.T500002-MCP20015684408
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367–1372. doi:10.1038/nbt.151119029910
   PubMed Web of Science ®Google Scholar
• Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10(4):1794–1805. doi:10.1021/pr101065j21254760
   PubMed Web of Science ®Google Scholar
• Choi H, Nesvizhskii AI. False discovery rates and related statistical concepts in mass spectrometry-based proteomics. J Proteome Res. 2008;7(1):47–50. doi:10.1021/pr700747q18067251
   PubMed Web of Science ®Google Scholar
• Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13(9):2513–2526. doi:10.1074/mcp.M113.03159124942700
   PubMed Web of Science ®Google Scholar
• Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, eds. Bioinformatics and Computational Biology Solutions Using R and Bioconductor, Statistics for Biology and Health. New York: Springer; 2005.
   Google Scholar
• Huang Da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13. doi:10.1093/nar/gkn92319033363
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang A, Yu F, et al. Label-free proteomics uncovers energy metabolism and focal adhesion regulations responsive for endometrium receptivity. J Proteome Res. 2015;14(4):1831–1842. doi:10.1021/acs.jproteome.5b0003825728905
   PubMed Web of Science ®Google Scholar
• Lédée N, Prat-Ellenberg L, Chevrier L, et al. Uterine immune profiling for increasing live birth rate: A one-to-one matched cohort study. J Reprod Immunol. 2017;119:23–30. doi:10.1016/j.jri.2016.11.00727915039
   PubMed Web of Science ®Google Scholar
• Hannan NJ, Evans J, Salamonsen LA. Alternate roles for immune regulators: establishing endometrial receptivity for implantation. Expert Rev Clin Immunol. 2011;7(6):789–802. doi:10.1586/eci.11.6522014020
   PubMed Web of Science ®Google Scholar
• Kitaya K, Yasuo T, Tada Y, et al. Unusual inflammation in gynecologic pathology associated with defective endometrial receptivity. Histol Histopathol. 2014;29(9):1113–1127.24771248
   PubMed Web of Science ®Google Scholar
• Reissmann T, Schally AV, Bouchard P, Riethmiiller H, Engel J. The LHRH antagonist cetrorelix: a review. Hum Reprod Update. 2000;6(4):322–331. doi:10.1093/humupd/6.4.32210972520
   PubMed Web of Science ®Google Scholar
• Ramakrishnappa N, Rajamahendran R, Lin YM, Leung PC. GnRH in non-hypothalamic reproductive tissues. Anim Reprod Sci. 2005;88(1–2):95–113. doi:10.1016/j.anireprosci.2005.05.00915982835
   PubMed Web of Science ®Google Scholar
• Impicciatore GG, Tiboni GM. Extrapituitary actions of GnRH antagonists: prospects for invitro fertilization programs. Curr Pharm Des. 2012;18(3):264–269. doi:10.2174/13816121279904035822229554
   PubMed Web of Science ®Google Scholar
• Gurka G, Rocklin RE. Reproductive immunology. JAMA. 1987;258(20):2983–2987. doi:10.1001/jama.1987.034002001890243312681
   PubMed Web of Science ®Google Scholar
• Whang DH, Kim SH, Park MH, Choi YM. Association of HLA-A, B antigens with susceptibility to advanced endometriosis in Koreans. Korean J Lab Med. 2008;28(2):118–123. doi:10.3343/kjlm.2008.28.2.11818458507
   PubMedGoogle Scholar
• Kitawaki J, Obayashi H, Kado N, et al. Association of HLA class I and class II alleles with susceptibility to endometriosis. Hum Immunol. 2002;63(11):1033–1038. doi:10.1016/S0198-8859(02)00438-X12392856
   PubMed Web of Science ®Google Scholar
• Sayegh RA, Tao XJ, Leykin L, Isaacson KB. Endometrial alpha-2 macroglobulin; localization by in situ hybridization and effect on mouse embryo development in vitro. J Clin Endocrinol Metab. 1997;82(12):4189–4195.9398738
   PubMed Web of Science ®Google Scholar
• Sayegh R, Awwad JT, Maxwell C, Lessey B, Isaacson K. Alpha 2-macroglobulin production by the human endometrium. J Clin Endocrinol Metab. 1995;80(3):1021–1026.7533769
   PubMed Web of Science ®Google Scholar
• Macklon NS, van der Gaast MH, Hamilton A, Fauser BC, Giudice LC. The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci. 2008;15(4):357–365. doi:10.1177/193371910731178118497344
   PubMed Web of Science ®Google Scholar